AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Embryonic development of multilineage hematopoiesis requires the precisely regulated expression of lineage-specific transcription factors, including AML-1 (encoded by Runx1; also known as CBFA-2 or PEBP-2alphaB). In vitro studies and findings in human diseases, including leukemias, myelodysplastic syndromes and familial platelet disorder with predisposition to acute myeloid leukemia (AML), suggest that AML-1 has a pivotal role in adult hematopoiesis. However, this role has not been fully uncovered in vivo because of the embryonic lethality of Runx1 knockout in mice. Here we assess the requirement of AML-1/Runx1 in adult hematopoiesis using an inducible gene-targeting method. In the absence of AML-1, hematopoietic progenitors were fully maintained with normal myeloid cell development. However, AML-1-deficient bone marrow showed inhibition of megakaryocytic maturation, increased hematopoietic progenitor cells and defective T- and B-lymphocyte development. AML-1 is thus required for maturation of megakaryocytes and differentiation of T and B cells, but not for maintenance of hematopoietic stem cells (HSCs) in adult hematopoiesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The transcription factor RUNX-1 plays a key role in megakaryocyte differentiation and is mutated in cases of myelodysplastic syndrome and leukemia.”
From Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. (2009) · cites this paper as [18]
In the citing paper
“Conditional knockout studies of mice demonstrate a specific role for RUNX-1 in megakaryocyte differentiation during adult stages of hematopoiesis”
From Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. (2009) · cites this paper as [18]
In the citing paper
“RUNX-1-deficient megakaryocytes have hypolobulated nuclei, underdeveloped cytoplasm, low DNA ploidy, and enhanced replating activity in semisolid medium culture assays.”
From Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development. (2009) · cites this paper as [18]
Citations
Cites
Identification of Clonogenic Common Lymphoid Progenitors in Mouse Bone Marrow
Kondo, M., Weissman, I. L., & Akashi, K. (1997) · Cell · doi:10.1016/s0092-8674(00)80453-5 · Cited by 2,253 · cited 1×
“1b ), the cells defined by Lin −/lo IL-7Rα + Sca-1 lo c-Kit lo , previously reported to include common lymphocyte progenitors (CLPs”
BackgroundLong-Term Lymphohematopoietic Reconstitution by a Single CD34-Low/Negative Hematopoietic Stem Cell
Osawa, M., Hanada, K.-I., Hamada, H., & Nakauchi, H. (1996) · Science · doi:10.1126/science.273.5272.242 · Cited by 2,140
Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G., & Downing, J. R. (1996) · Cell · doi:10.1016/s0092-8674(00)80986-1 · Cited by 1,856
Inducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641 · cited 1×
“Here we assess the requirement of AML-1/ Runx1 in adult hematopoiesis using an inducible gene-targeting metho”
MethodWang, Q., Stacy, T., Binder, M., Marin-Padilla, M., Sharpe, A. H., & Speck, N. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3444 · Cited by 1,178
Song, W.-J., Sullivan, M. G., Legare, R. D., Hutchings, S., Tan, X., Kufrin, D., Ratajczak, J., Resende, I. C., Haworth, C., Hock, R., et al. (1999) · Nature Genetics · doi:10.1038/13793 · Cited by 1,100
Transcription Factors, Normal Myeloid Development, and Leukemia
Tenen, D. G., Hromas, R., Licht, J. D., & Zhang, D.-E. (1997) · Blood · doi:10.1182/blood.v90.2.489 · Cited by 735 · cited 1×
“In vitro studies and findings in human diseases, including leukemia”
BackgroundTaniuchi, I., Osato, M., Egawa, T., Sunshine, M. J., Bae, S.-C., Komori, T., Ito, Y., & Littman, D. R. (2002) · Cell · doi:10.1016/s0092-8674(02)01111-x · Cited by 730
Shivdasani, R. A., Fujiwara, Y., McDevitt, M. A., & Orkin, S. H. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3965 · Cited by 674
North, T. E., de Bruijn, M. F. T. R., Stacy, T., Talebian, L., Lind, E., Robin, C., Binder, M., Dzierzak, E., & Speck, N. A. (2002) · Immunity · doi:10.1016/s1074-7613(02)00296-0 · Cited by 583
Cited by
Items 101–200 of 595
Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model
Fischer, M., Schwieger, M., Horn, S., Niebuhr, B., Ford, A. M., Roscher, S., Bergholz, U., Greaves, M. F., Löhler, J., & Stocking, C. (2005) · Oncogene · doi:10.1038/sj.onc.1208931 · Cited by 111
Effect of transcription-factor concentrations on leukemic stem cells
Rosenbauer, F., Koschmieder, S., Steidl, U., & Tenen, D. G. (2005) · Blood · doi:10.1182/blood-2005-02-0717 · Cited by 98
Runx2 in normal tissues and cancer cells: A developing story
Blyth, K., Vaillant, F., Jenkins, A., McDonald, L., Pringle, M. A., Huser, C. A. M., Stein, T., Neil, J. C., & Cameron, E. R. (2010) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2010.05.007 · Cited by 97
Guo, H. W., Ma, O., Speck, N. A., & Friedman, A. D. (2012) · Blood · doi:10.1182/blood-2011-12-397091 · Cited by 107
A Runx1 Intronic Enhancer Marks Hemogenic Endothelial Cells and Hematopoietic Stem Cells
Ng, C. E. L., Yokomizo, T., Yamashita, N., Cirovic, B., Jin, H., Wen, Z., Ito, Y., & Osato, M. (2010) · Stem Cells · doi:10.1002/stem.507 · Cited by 104
Development of multilineage adult hematopoiesis in the zebrafish with a runx1 truncation mutation
Sood, R., English, M. A., Belele, C. L., Jin, H., Bishop, K., Haskins, R., McKinney, M. C., Chahal, J., Weinstein, B. M., Wen, Z., et al. (2010) · Blood · doi:10.1182/blood-2009-08-236729 · Cited by 94
Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells
Spender, L. C., Whiteman, H. J., Karstegl, C. E., & Farrell, P. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208404 · Cited by 105
The RUNX1–PU.1 axis in the control of hematopoiesis
Imperato, M. R., Cauchy, P., Obier, N., & Bonifer, C. (2015) · International Journal of Hematology · doi:10.1007/s12185-015-1762-8 · Cited by 94
Distinct temporal requirements for Runx1 in hematopoietic progenitors and stem cells
Tober, J. M., Yzaguirre, A. D., Piwarzyk, E., & Speck, N. A. (2013) · Development · doi:10.1242/dev.094961 · Cited by 106
“Runx1deficient LT-HSCs also contribute less efficiently than do wildtype LT-HSCs to differentiated cells in peripheral blood (Cai et al., 2011; Growney et al., 2005; Ichikawa et al., 2004).”
BackgroundVoon, D. C., Wang, H., Koo, J. K. W., Nguyen, T. A. P., Hor, Y. T., Chu, Y., Ito, K., Fukamachi, H., Chan, S. L., Thiery, J. P., et al. (2012) · Stem Cells · doi:10.1002/stem.1183 · Cited by 96
The Diverse Biological Roles of MYST Histone Acetyltransferase Family Proteins
Thomas, T., & Voss, A. K. (2007) · Cell Cycle · doi:10.4161/cc.6.6.4013 · Cited by 102
The AS‐RBM15 lncRNA enhances RBM15 protein translation during megakaryocyte differentiation
Tran, N. T., Su, H., Khodadadi‐Jamayran, A., Lin, S., Zhang, L., Zhou, D., Pawlik, K. M., Townes, T. M., Chen, Y., Mulloy, J. C., et al. (2016) · EMBO Reports · doi:10.15252/embr.201541970 · Cited by 92
“Like RBM15, RUNX1 is required for the self-renewal of hematopoietic stem cells and for megakaryocyte differentiation [30,31].”
ERG promotes the maintenance of hematopoietic stem cells by restricting their differentiation
Knudsen, K. J., Rehn, M., Hasemann, M. S., Rapin, N., Bagger, F. O., Ohlsson, E., Willer, A., Frank, A.-K., Søndergaard, E., Jendholm, J., et al. (2015) · Genes & Development · doi:10.1101/gad.268409.115 · Cited by 98
Sun, L., Gorospe, J. R., Hoffman, E. P., & Rao, A. K. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.02271.x · Cited by 88
Kit-Shp2-Kit signaling acts to maintain a functional hematopoietic stem and progenitor cell pool
Zhu, H. H., Ji, K., Alderson, N. B., He, Z., Li, S., Liu, W., Zhang, D., Li, L., & Feng, G. (2011) · Blood · doi:10.1182/blood-2011-01-333476 · Cited by 94
Stem cell expression of the AML1/ETO fusion protein induces a myeloproliferative disorder in mice
Fenske, T. S., Pengue, G., Mathews, V., Hanson, P. T., Hamm, S. E., Riaz, N., & Graubert, T. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400751101 · Cited by 101
Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development.
Huang, H., Yu, M., Akie, T. E., Moran, T. B., Woo, A. J., Tu, N., Waldon, Z., Lin, Y. Y., Steen, H., & Cantor, A. B. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00090-09 · Cited by 87
“These include GATA-1 (46, 57), GATA-2 (4), Friend of GATA-1 (FOG-1) (55), NF-E2 p45 (47), mafG and mafK (39), SCL/Tal1 (30), GABP (41), FLI-1 (17, 49), ZBP-89 (62), and RUNX-1 (14, 18).”
BackgroundQiu, J., & Zhou, L. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0393-5 · Cited by 95
Ochi, Y., Kon, A., Sakata, T., Nakagawa, M. M., Nakazawa, N., Kakuta, M., Kataoka, K., Koseki, H., Nakayama, M., Morishita, D., et al. (2020) · Cancer Discovery · doi:10.1158/2159-8290.cd-19-0982 · Cited by 95
“Runx1 conditional knockout mice were described previously (49).”
BackgroundSelf-citationHematopoietic stem cell emergence in the conceptus and the role of Runx1
Swiers, G., Bruijn, M. F. T. R. D., & Speck, N. A. (2010) · The International Journal of Developmental Biology · doi:10.1387/ijdb.103106gs · Cited by 101
“…causes not a reduction, but rather an expansion of phenotypic HSCs and progenitors in the bone marrow (Chen et al., 2009; Growney et al., 2005; Ichikawa et al., 2004; Putz et al., 2006; Schindler et al., 2009), thus at some point hematopoietic stem and progenitor cells no longer absolutely…”
RUNX1 is required for oncogenic Myb and Myc enhancer activity in T-cell acute lymphoblastic leukemia
Choi, A., Illendula, A., Pulikkan, J. A., Roderick, J. E., Tesell, J., Yu, J., Hermance, N. M., Zhu, L. J., Castilla, L. H., Bushweller, J. H., et al. (2017) · Blood · doi:10.1182/blood-2017-03-775536 · Cited by 93
Kohu, K., Sato, T., Ohno, S.-I., Hayashi, K., Uchino, R., Abe, N., Nakazato, M., Yoshida, N., Kikuchi, T., Iwakura, Y., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.5.2627 · Cited by 85
“Conditional targeting of Runx1 has also revealed that it has an indispensable role in the initial emergence of T-committed cells from stem cells (12).”
BackgroundKanagal-Shamanna, R., Loghavi, S., DiNardo, C. D., Medeiros, L. J., Garcia-Manero, G., Jabbour, E., Routbort, M. J., Luthra, R., Bueso-Ramos, C. E., & Khoury, J. D. (2017) · Haematologica · doi:10.3324/haematol.2017.167726 · Cited by 84
Runx1/AML1 in Normal and Abnormal Hematopoiesis
Yamagata, T., Maki, K., & Mitani, K. (2005) · International Journal of Hematology · doi:10.1532/ijh97.05075 · Cited by 93
Self-citationMolecular mechanisms of megakaryopoiesis
Szalai, G., LaRue, A. C., & Watson, D. K. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6190-8 · Cited by 125
Jalagadugula, G. S., Mao, G., Kaur, G., Goldfinger, L. E., Dhanasekaran, D. N., & Rao, A. K. (2010) · Blood · doi:10.1182/blood-2010-06-289850 · Cited by 90
AML1/Runx1 Negatively Regulates Quiescent Hematopoietic Stem Cells in Adult Hematopoiesis
Ichikawa, M., Goyama, S., Asai, T., Kawazu, M., Nakagawa, M., Takeshita, M., Chiba, S., Ogawa, S., & Kurokawa, M. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.7.4402 · Cited by 83
Self-citationIsoform-Specific Potentiation of Stem and Progenitor Cell Engraftment by AML1/RUNX1
Tsuzuki, S., Hong, D., Gupta, R., Matsuo, K., Seto, M., & Enver, T. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040172 · Cited by 83
“1 mM 2-mercaptoethanol, and 10 units of mouse thrombopoietin (Peprotech) was used [7].”
MethodOhno, S., Sato, T., Kohu, K., Takeda, K., Okumura, K., Satake, M., & Habu, S. (2007) · International Immunology · doi:10.1093/intimm/dxm120 · Cited by 100
Sakurai, M., Kunimoto, H., Watanabe, N., Fukuchi, Y., Yuasa, S., Yamazaki, S., Nishimura, T., Sadahira, K., Fukuda, K., Okano, H., et al. (2014) · Leukemia · doi:10.1038/leu.2014.136 · Cited by 96
Runx1Protects Hematopoietic Stem/Progenitor Cells from Oncogenic Insult
Motoda, L., Osato, M., Yamashita, N., Jacob, B., Chen, L. Q., Yanagida, M., Ida, H., Wee, H., Sun, A. X., Taniuchi, I., et al. (2007) · Stem Cells · doi:10.1634/stemcells.2007-0061 · Cited by 82
Runx1 Loss Minimally Impacts Long-Term Hematopoietic Stem Cells
Cai, X., Gaudet, J., Mangan, J. K., Chen, M. J., Obaldia, M. E. D., Oo, Z. M., Ernst, P., & Speck, N. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028430 · Cited by 92
“[16] previously reported that LT-HSC frequencies were elevated 10 fold when Runx1 was deleted in all bone marrow cells with Mx1-Cre, which they assessed by PCR analysis for Y-chromosome positive donor-derived cells in the bone marrow of female recipients.”
BackgroundResultInfluentialNakamura, M., & Shimizu, T. (2011) · Chemical Reviews · doi:10.1021/cr100392s · Cited by 81
RUNX1 Mutations in Inherited and Sporadic Leukemia
Bellissimo, D. C., & Speck, N. A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00111 · Cited by 84
“Initial reports showed that deletion of Runx1 in hematopoietic cells caused an expansion of HSPCs (lineage negative Sca1+ Kit+ cells) and committed myeloid progenitors in the bone marrow (Ichikawa et al., 2004; Growney et al., 2005).”
BackgroundInfluentialCommon features of megakaryocytes and hematopoietic stem cells: What's the connection?
Huang, H., & Cantor, A. B. (2009) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22184 · Cited by 94
“Conditional knockout studies using the Mx1-Cre system, which allows inducible deletion of targeted alleles within the bone marrow, also show a requirement for Runx1 during Mk differentiation in adult animals [Ichikawa et al., 2004; Growney et al., 2005].”
RUNX1 contributes to the mesenchymal subtype of glioblastoma in a TGFβ pathway-dependent manner
Zhao, K., Cui, X., Wang, Q., Fang, C., Tan, Y., Wang, Y., Yi, K., Yang, C., You, H., Shang, R., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2108-x · Cited by 88
Bellissimo, D. C., Chen, C.-H., Zhu, Q., Bagga, S., Lee, C.-T., He, B., Wertheim, G. B. W., Jordan, M. S., Tan, K., Worthen, G. S., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000785 · Cited by 83
Runx1 is involved in primitive erythropoiesis in the mouse
Yokomizo, T., Hasegawa, K., Ishitobi, H., Osato, M., Ema, M., Ito, Y., Yamamoto, M., & Takahashi, S. (2008) · Blood · doi:10.1182/blood-2007-05-091637 · Cited by 78
Connelly, J. P., Kwon, E. M., Gao, Y., Trivedi, N. S., Elkahloun, A. G., Horwitz, M. S., Cheng, L., & Liu, P. (2014) · Blood · doi:10.1182/blood-2014-01-550525 · Cited by 81
“On the other hand, induced pluripotent stem cells (iPSCs) have the potential to differentiate into many cell types of the human body so that they may be used to model many human diseases as well as to serve as a valuable resource in thefield of regenerativemedicine.(16-18) If disease-causingmutations can be corrected…”
BackgroundHock, H. R., & Orkin, S. H. (2005) · Current Opinion in Hematology · doi:10.1097/01.moh.0000190111.85284.8f · Cited by 90
Kuhl, C., Atzberger, A., Iborra, F. J., Nieswandt, B., Porcher, C., & Vyas, P. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.19.8592-8606.2005 · Cited by 92
“However, in that study RUNX1 independently interacted with both the N- and C-terminal GATA1 domains.”
BackgroundCDK6 inhibits white to beige fat transition by suppressing RUNX1
Hou, X. S., Zhang, Y., Li, W., Hu, A. J., Luo, C., Zhou, W., Hu, J. K., Daniele, S. G., Wang, J., Sheng, J., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03451-1 · Cited by 78
Critical role of P1-Runx1 in mouse basophil development
Mukai, K., BenBarak, M. J., Tachibana, M., Nishida, K., Karasuyama, H., Taniuchi, I., & Galli, S. J. (2012) · Blood · doi:10.1182/blood-2011-12-399113 · Cited by 76
Jo, M., & Curry, T. E. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0512 · Cited by 79
“RUNX1 has been shown to play an essential role in differentiation of various cell types (8, 10, 11, 13).”
BackgroundEndothelial progenitor cells: A source for therapeutic vasculogenesis?
Rumpold, H. F., Wolf, D. G. F., Koeck, R., & Gunsilius, E. (2004) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2004.tb00475.x · Cited by 89
“Due to the lethal phenotype of AML1 -/- mice they assessed the role of Runx1 in an inducible gene-target model and could show that in the absence of AML1 the bone marrow showed inhibition of megakaryocytic maturation, increased hematopoietic progenitor cells and defective T- and B-lymphocyte development [17].”
BackgroundMethodGenetic programs regulating HSC specification, maintenance and expansion
Lessard, J. A., Faubert, A., & Sauvageau, G. (2004) · Oncogene · doi:10.1038/sj.onc.1207940 · Cited by 88
RUNX1‐dependent mechanisms in biological control and dysregulation in cancer
Hong, D., Fritz, A. J., Gordon, J. A. R., Tye, C. E., Boyd, J. R., Tracy, K. M., Frietze, S. E., Carr, F. E., Nickerson, J. A., van Wijnen, A. J., et al. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27841 · Cited by 83
“For example, RUNX1 is necessary for megakaryocytic maturation and differentiation of B‐cells and T‐cells in mouse bone marrow (Ichikawa et al., 2004; Niebuhr et al., 2013; Seo, Ikawa, Kawamoto, & Taniuchi, 2012).”
BackgroundYang, Y., Kueh, A. J., Grant, Z. L., Abeysekera, W., Garnham, A. L., Wilcox, S., Hyland, C. D., Rago, L. D., Metcalf, D., Alexander, W. S., et al. (2021) · Blood · doi:10.1182/blood.2021013954 · Cited by 80
Guo, Y., Maillard, I., Chakraborti, S., Rothenberg, E. V., & Speck, N. A. (2008) · Blood · doi:10.1182/blood-2007-10-120261 · Cited by 74
Potts, K. S., Sargeant, T., Markham, J. F., Shi, W., Biben, C., Josefsson, E. C., Whitehead, L. W., Rogers, K. L., Liakhovitskaia, A., Smyth, G. K., et al. (2014) · Blood · doi:10.1182/blood-2014-02-559468 · Cited by 80
2014 Jeffrey M. Hoeg Award Lecture: Transcriptional Control of Monocyte Development
Zhu, Y. P., Thomas, G. D., & Hedrick, C. C. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.304054 · Cited by 91
“Runx 1 Runt-related transcription factor-1 (RUNX1; also known as acute myeloid leukemia-1) is a critical transcriptional regulator of hematopoiesis.(99,100) RUNX1 is often dysregulated in myeloid leukemias.”
BackgroundFeng, J., Iwama, A., Satake, M., & Kohu, K. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07632.x · Cited by 79
“…cells during embryogenesis (Okuda et al, 1996; Wang et al, 1996; Okada et al, 1998) and that it also plays essential roles in the differentiation of lymphocytes, megakaryocytes and granulocytes in adult mice (Hayashi et al, 2000; Taniuchi et al, 2002; Ichikawa et al, 2004; Growney et al, 2005).”
BackgroundPozner, A., Lotem, J., Xiao, C., Goldenberg, D., Brenner, O., Negreanu, V., Levanon, D., & Groner, Y. (2007) · BMC Developmental Biology · doi:10.1186/1471-213x-7-84 · Cited by 74
“Postnatally, Runx1 is highly expressed in several hematopoietic lineages including myeloid, B- and T-lymphoid cells [2,21,22] and is required for megakaryocytic maturation [23].”
Twist-2 Controls Myeloid Lineage Development and Function
Sharabi, A. B., Aldrich, M., Sosic, D., Olson, E. N., Friedman, A. D., Lee, S.-H., & Chen, S.-Y. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060316 · Cited by 74
“translocations t(8;21) in acute myeloid leukemia (AML), which generates the dominant-negative Runx1-ETO fusion protein to suppress Runx1 activity, leading to the blockade of myeloid lineage differentiation and an accumulated progenitor pool that is prone to malignant transformation [60].”
BackgroundC/EBPα deregulation as a paradigm for leukemogenesis
Pulikkan, J. A., Tenen, D. G., & Behre, G. (2017) · Leukemia · doi:10.1038/leu.2017.229 · Cited by 79
Bee, T., Swiers, G., Muroi, S., Pozner, A., Nottingham, W. T., SANTOS, A. C. D. S., Li, P.-S., Taniuchi, I., & Bruijn, M. F. T. R. D. (2010) · Blood · doi:10.1182/blood-2009-08-238626 · Cited by 86
Role of Transcription Factors C/EBPa and PU.1 in Normal Hematopoiesis and Leukemia
Koschmieder, S., Rosenbauer, F., Steidl, U., Owens, B. M., & Tenen, D. G. (2005) · International Journal of Hematology · doi:10.1532/ijh97.05051 · Cited by 72
“AML1 [12, 24 ] Hematopoietic cells, nerve tissue, Lack of all definitive Impaired megakaryocytic M-CSFR, PU.1 skeletal muscle, reproductive hematopoiesis maturation, defective B-cell tissue and T-cell development”
BackgroundMethodKatsumoto, T., Yoshida, N., & Kitabayashi, I. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00865.x · Cited by 79
The Role of Runx1 in Embryonic Blood Cell Formation
Yzaguirre, A. D., Bruijn, M. F. T. R. D., & Speck, N. A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-3233-2_4 · Cited by 77
“However, Runx1 deletion in hematopoietic cells does cause defects that include thrombocytopenia and defective lymphopoiesis in adult mice (Chen et al., 2009, Ichikawa et al., 2004, Growney et al., 2005, Putz et al., 2006).”
BackgroundT-lymphoid, megakaryocyte, and granulocyte development are sensitive to decreases in CBFβ dosage.
Talebian, L., Li, Z., Guo, Y., Gaudet, J., Speck, M. E., Sugiyama, D., Kaur, P., Pear, W. S., Maillard, I., & Speck, N. A. (2007) · Blood · doi:10.1182/blood-2006-05-021188 · Cited by 70
“Western blot quantification of endogenous CBF was performed by comparison to known amounts of bacterially produced and purified CBF (1-141).”
Hematopoietic Stem Cells: Transcriptional Regulation, Ex Vivo Expansion and Clinical Application
Aggarwal, R., Lu, J., Pompili, V. J., & Das, H. (2011) · Current Molecular Medicine · doi:10.2174/156652412798376125 · Cited by 85
“However, Runx1/AML1 is not essential for functioning of adult definitive HSCs, while it is critical for lymphoid and megakaryocyte functioning [39, 40].”
BackgroundHematopoietic transcription factor mutations: important players in inherited platelet defects
Songdej, N., & Rao, A. K. (2017) · Blood · doi:10.1182/blood-2016-11-709881 · Cited by 75
“Conditional RUNX1 knockouts in mouse models show impaired MK maturation, with presence of abnormal micro-MKs and significant reduction in MK polyploidization.(23) In patients with RUNX1 mutations, MKs cultured from stem cells also demonstrate defects in differentiation and polyploidization.”
BackgroundHuang, H., Woo, A. J., Waldon, Z., Schindler, Y., Moran, T. B., Zhu, H. H., Feng, G.-S., Steen, H., & Cantor, A. B. (2012) · Genes & Development · doi:10.1101/gad.192054.112 · Cited by 70
“Inducible RUNX1 loss also results in impaired Mk and lymphocyte differentiation as well as a mild myeloproliferative disorder (Ichikawa et al. 2004; Growney et al. 2005).”
BackgroundInfluentialNiimi, H., Harada, H., Harada, Y., Ding, Y., Imagawa, J., Inaba, T., Kyo, T., & Kimura, A. (2006) · Leukemia · doi:10.1038/sj.leu.2404136 · Cited by 69
Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia
Galera, P. K., Dulau‐Florea, A., & Calvo, K. R. (2019) · International Journal of Laboratory Hematology · doi:10.1111/ijlh.12999 · Cited by 79
PEBP2-β/CBF-β–dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis
Wee, H.-J., Voon, D. C.-C., Bae, S.-C., & Ito, Y. (2008) · Blood · doi:10.1182/blood-2008-01-134122 · Cited by 69
Core binding factor at the crossroads: Determining the fate of the HSC
Link, K. A., Chou, F., & Mulloy, J. C. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21950 · Cited by 70
“Conditional targeting of Runx1 is also associated with an expansion of myeloid progenitors, a phenotype possibly attributable to a partial block in myeloid differentiation or as a result of myeloid-biased differentiation of HSC (Ichikawa et al., 2004; Growney et al., 2005).”
BackgroundInfluentialFei, D. L., Zhen, T., Durham, B. H., Ferrarone, J. R., Zhang, T., Garrett, L. J., Yoshimi, A., Abdel-Wahab, O. I., Bradley, R. K., Liu, P., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812669115 · Cited by 88
“thrombocytopenia, increased percentage of myeloid cells, and increased myeloid colony formation;; (28, 29)), as shown in Fig.”
Normal and transforming functions of RUNX1: A perspective
Mikhail, F. M., Sinha, K. K., Saunthararajah, Y., & Nucifora, G. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20538 · Cited by 81
“The BM of the mice appeared normal and hematopoietic progenitor compartment was maintained or even expanded (Ichikawa et al., 2004), however recent Fig.”
BackgroundInfluentialPosttranslational modifications of RUNX1 as potential anticancer targets
Goyama, S., Huang, G., Kurokawa, M., & Mulloy, J. C. (2014) · Oncogene · doi:10.1038/onc.2014.305 · Cited by 75
Self-citationThe RUNX complex: reaching beyond haematopoiesis into immunity
Voon, D. C., Hor, Y. T., & Ito, Y. (2015) · Immunology · doi:10.1111/imm.12535 · Cited by 67
Runx1 function in hematopoiesis is required in cells that express Tek
Li, Z., Chen, M. J., Stacy, T., & Speck, N. A. (2005) · Blood · doi:10.1182/blood-2005-05-1955 · Cited by 73
Molecular mechanisms that control mouse and human TCR-αβ and TCR-γδ T cell development
Taghon, T., & Rothenberg, E. V. (2008) · Seminars in Immunopathology · doi:10.1007/s00281-008-0134-3 · Cited by 89
“expression peaks at the DN3 stage [101] and is specifically required for αβ lineage differentiation at the β selection checkpoint [102, 100].”
Tsai, S., Shih, L., Liang, S., Huang, Y., Kuo, M., Huang, C., Shih, Y., Lin, T., Chiu, M.-C., & Liang, D. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2203 · Cited by 72
Transcription factor mutations as a cause of familial myeloid neoplasms
Churpek, J. E., & Bresnick, E. H. (2019) · Journal of Clinical Investigation · doi:10.1172/jci120854 · Cited by 63
Zebrafish runx1 promoter-EGFP transgenics mark discrete sites of definitive blood progenitors
Lam, E. Y. N., Chau, J. Y. M., Kalev‐Zylinska, M. L., Fountaine, T. M., Mead, R. S., Hall, C. J., Crosier, P. S., Crosier, K. E., & Flores, M. V. (2008) · Blood · doi:10.1182/blood-2008-04-149898 · Cited by 71
Hoogenkamp, M., Krysinska, H., Ingram, R., Huang, G., Barlow, R., Clarke, D., Ebralidze, A., Zhang, P., Tagoh, H., Cockerill, P. N., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00905-07 · Cited by 63
“These studies showed that, although RUNX1 is vital for hematopoietic development, it is dispensable for adult hematopoiesis and myelopoiesis (11, 14).”
BackgroundMolecular insights into Down syndrome-associated leukemia
Vyas, P., & Crispino, J. D. (2007) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328013e7b2 · Cited by 65
Bluteau, D., Gilles, L., Hilpert, M., Antony‐Debré, I., James, C., Debili, N., Camara‐Clayette, V., Wagner‐Ballon, O., Cordette-Lagarde, V., Robert, T., et al. (2011) · Blood · doi:10.1182/blood-2010-12-325555 · Cited by 64
Runx1 is essential at two stages of early murine B-cell development
Niebuhr, B., Kriebitzsch, N., Fischer, M., Behrens, K., Günther, T., Alawi, M., Bergholz, U., Müller, U., Roscher, S., Ziegler, M., et al. (2013) · Blood · doi:10.1182/blood-2013-01-480244 · Cited by 62
Erythroid and megakaryocytic transformation
Wickrema, A., & Crispino, J. D. (2007) · Oncogene · doi:10.1038/sj.onc.1210763 · Cited by 80
Advances in the molecular pathobiology of B-lymphoblastic leukemia
Zhou, Y., You, M. J., Young, K. H., Lin, P., Lu, G. G., Medeiros, L. J., & Bueso-Ramos, C. (2012) · Human Pathology · doi:10.1016/j.humpath.2012.02.004 · Cited by 72
“t(12;21)(p13;q22) ETV6-RUNX1 (TEL-AML1) fusion RUNX1, located on chromosome 21q22 and previously known as AML1, is a transcription factor that is required for hematopoietic development at an early embryonic stage as well as T- and B-cell differentiation in adult hematopoiesis [57].”
BackgroundEx Vivo production of platelets from stem cells
Avanzi, M. P., & Mitchell, W. B. (2014) · British Journal of Haematology · doi:10.1111/bjh.12764 · Cited by 65
Progression of regulatory gene expression states in fetal and adult pro-T-cell development
David‐Fung, E., Yui, M. A., Morales, M., Wang, H., Taghon, T., Diamond, R. A., & Rothenberg, E. V. (2006) · Immunological Reviews · doi:10.1111/j.0105-2896.2006.00355.x · Cited by 60
Phosphorylation of RUNX1 by Cyclin-dependent Kinase Reduces Direct Interaction with HDAC1 and HDAC3
Guo, H., & Friedman, A. D. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.149013 · Cited by 60
Vishwakarma, B. A., Nguyen, N. A., Makishima, H., Hosono, N., Gudmundsson, K. O., Negi, V., Oakley, K., Han, Y., Przychodzen, B. P., Maciejewski, J., et al. (2015) · Leukemia · doi:10.1038/leu.2015.200 · Cited by 62
Histone arginine methylation keeps RUNX1 target genes in an intermediate state
Herglotz, J., Kuvardina, O. N., Kolodziej, S., Kumar, A., Hussong, H., Grez, M., & Lausen, J. (2012) · Oncogene · doi:10.1038/onc.2012.274 · Cited by 65
Role of the renin-angiotensin system in primitive erythropoiesis in the chick embryo
Savary, K., Michaud, A., Favier, J., Larger, É., Corvol, P. L., & Gasc, J. (2004) · Blood · doi:10.1182/blood-2004-04-1570 · Cited by 68
Nakagawa, M. M., Shimabe, M., Watanabe‐Okochi, N., Arai, S., Yoshimi, A., Shinohara, A., Nishimoto, N., Kataoka, K., Sato, T., Kumano, K., et al. (2011) · Blood · doi:10.1182/blood-2010-12-326710 · Cited by 69
Self-citationTranscriptional Regulation of Haematopoietic Stem Cells
Wilkinson, A. C., & Göttgens, B. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-6621-1_11 · Cited by 76
P19INK4D links endomitotic arrest and megakaryocyte maturation and is regulated by AML-1
Gilles, L., Guièze, R., Bluteau, D., Cordette-Lagarde, V., Lacout, C., Favier, R., Larbret, F., Debili, N., Vainchenker, W., & Raslová, H. (2008) · Blood · doi:10.1182/blood-2007-09-113266 · Cited by 71
Roß, K., Sedello, A., Todd, G. P., Paszkowski‐Rogacz, M., Bird, A. W., Ding, L., Grinenko, T., Behrens, K., Hubner, N. C., Mann, M., et al. (2012) · Blood · doi:10.1182/blood-2011-09-382390 · Cited by 63
“Bird, 2 , Li Ding, 1,2 Tatyana Grinenko, 4 Kira Behrens, 5 Nina Hubner, 3,$ Matthias Mann, 3 Claudia Waskow,(4) Carol Stocking,(5) and Frank Buchholz.(1,2)”
Translating the histone code into leukemia
Linggi, B. E., Brandt, S. J., Sun, Z., & Hiebert, S. W. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20604 · Cited by 67
Steensma, D. P., Gibbons, R. J., Mesa, R. A., Tefferi, A., & Higgs, D. R. (2005) · European Journal of Haematology · doi:10.1111/j.1600-0609.2004.00363.x · Cited by 58
“1 RA (hx AML)(2) 47, XY, del(20)q11; +8 360_365dupTACCGC T121_A122dup None 2 RAEB-2 46, XY 514G>A G172R Loss FokI site 3 RAEB-2 46, XX, t(1;3)(p36;q21) 266T>C F89S New StyI site 4 RAEB-2 46, XY, +8, )16 403A>G R135G New BsaJI site 5 RAEB-2 Unsuccessful (dry tap) 211delC L71SfsX94 Loss MnlI site”
BackgroundCharacterization of GATA‐1+ hemangioblastic cells in the mouse embryo
Yokomizo, T., Takahashi, S., Mochizuki, N., Kuroha, T., Ema, M., Wakamatsu, A., Shimizu, R., Ohneda, O., Osato, M., Okada, H., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601480 · Cited by 60
“Similarly, conditional targeting of Runx1 in adult mice did not influence maintenance of the HSC population (Ichikawa et al, 2004).”
BackgroundEzh2 and Runx1 Mutations Collaborate to Initiate Lympho-Myeloid Leukemia in Early Thymic Progenitors
Booth, C. A. G., Barkas, N., Neo, W. H., Boukarabila, H., Soilleux, E. J., Giotopoulos, G., Farnoud, N., Giustacchini, A., Ashley, N., Carrelha, J., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.01.006 · Cited by 57
“Although loss of Runx1 is associated with megakaryocyte maturation defects (Ichikawa et al., 2004), no significant impact on platelet counts were seen upon Runx1 or Ezh2 deletion (Figure 1B), in keeping with absence of Rag1Cre-induced deletion during megakaryocytic differentiation (Boiers et al.”
BackgroundGoyama, S., Yamaguchi, Y., Imai, Y., Kawazu, M., Nakagawa, M. M., Asai, T., Kumano, K., Mitani, K., Ogawa, S., Chiba, S., et al. (2004) · Blood · doi:10.1182/blood-2004-04-1535 · Cited by 59
Self-citationCBFβ is critical for AML1-ETO and TEL-AML1 activity
Roudaia, L., Cheney, M. D., Manuylova, E., Chen, W., Morrow, M., Park, S., Lee, C.-T., Kaur, P., Williams, O., Bushweller, J. H., et al. (2009) · Blood · doi:10.1182/blood-2008-03-147207 · Cited by 59
“We were unable to detect AML1-ETO protein in spleen samples from any of the transplanted mice using antibodies that recognize either ETO or the Runt domain from Runx1, although we could detect the protein in Kasumi-1 cells which contain the t(8;21), and actin was clearly visible in all of the samples (not shown).”
BackgroundTranscriptional control of megakaryocyte development
Goldfarb, A. N. (2007) · Oncogene · doi:10.1038/sj.onc.1210762 · Cited by 65
Xu, G., Kanezaki, R., Toki, T., Watanabe, S., Takahashi, Y., Terui, K., Kitabayashi, I., & Ito, E. (2006) · Leukemia · doi:10.1038/sj.leu.2404223 · Cited by 65
Metadata
- Authors
- Ichikawa, M., Asai, T., Saito, T., Yamamoto, G., Seo, S., Yamazaki, I., Yamagata, T., Mitani, K., Chiba, S., Hirai, H., Ogawa, S., & Kurokawa, M.
- Affiliations
- The University of Tokyo (JP)
- Inoue Hospital (JP)
- Joslin Diabetes Center (US)
- Dokkyo University (JP)
- Corresponding author
- Ogawa, Seishi
- ORCID
- Venue
- Nature Medicine
- Published
- 2004-02-15
- Volume
- 10
- Issue
- 3
- Pages
- 299-304
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2101518963
- Cited by
- 596
- References
- 29
- Citations by year
- 2026: 11 · 2025: 5 · 2024: 10 · 2023: 12 · 2022: 16 · 2021: 28 · 2020: 18 · 2019: 22 · 2018: 20 · 2017: 33 · 2016: 26 · 2015: 23 · 2014: 24 · 2013: 29 · 2012: 27
- FWCI
- 30.73
- Type
- journal article
- Language
- en
- Update notices
- erratum (2005-01-01)
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Health Sciences › Medicine › Hematology › Platelet Disorders and Treatments
- Keywords
- RUNX1, lymphocyte differentiation, T cell development, B cell development, hematopoietic stem cells, hematopoietic progenitor cells, adult hematopoiesis, myelodysplastic syndrome
- MeSH terms
- Adult, Animals, Bone Marrow Cells, Cell Differentiation, DNA-Binding Proteins, Hematopoiesis, Hematopoietic Stem Cells, Humans, Lymphocytes, Megakaryocytes, Mice, Inbred Strains, Mice, Transgenic, Proto-Oncogene Proteins, Transcription Factors, Gene Targeting, Cell Lineage, Cell Size, Core Binding Factor Alpha 2 Subunit, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.